Investing Ideas
/
Hong Kong Pharmaceuticals & Biotech Buy the Dip

Hong Kong Pharmaceuticals & Biotech Buy the Dip

Results

1 new

Companies which have seen a dip in the last 7 days after continued gains and are looking undervalued based on Snowflake checks.

2 companies

Mabpharm

Market Cap: HK$2.1b

A biopharmaceutical company, engages in research, development, production, and commercialization of drugs and biosimilar for cancers and autoimmune diseases in the People’s Republic of China.

New

2181

HK$0.52

-13.3%

55.2%

Sirnaomics

Market Cap: HK$1.0b

An RNA therapeutics biopharmaceutical company, discovers and develops drugs for indications with medical needs.

2257

HK$9.77

-14.6%

226.8%